Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Description
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat infections in high-risk patients. Here, we report the adaptation of SARS-CoV-2 to the
